Patient-centered Dosage of Levothyroxine

NARecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
HypothyroidismThyroid CancerThyroid
Interventions
OTHER

Decision support tool

Patients in the intervention groups are given the option to use the decision support tool when adjusting the levothyroxine dose after total thyroidectomy. Levothyroxine therapy is not a part of the intervention, as all patients receive this therapy regardless of study participation.

Trial Locations (3)

9010

RECRUITING

University Hospital of North Norway, Tromsø

Unknown

RECRUITING

Haukeland University Hospital, Bergen

RECRUITING

Oslo University Hospital, Oslo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

SINTEF Health Research

OTHER

collaborator

Helseapps

UNKNOWN

collaborator

Norinnova

UNKNOWN

collaborator

Helse Nord

INDUSTRY

lead

University Hospital of North Norway

OTHER